Research on HDAC6 is being vigorously pursued for its role in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases as well as in cancers and use of HDAC6 specific inhibitors has been demonstrated to be beneficial in animal models [25, 26]. This evidence concerns the gene HDAC6 and cancer.